Filing Details

Accession Number:
0001140361-17-033130
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-23 21:03:03
Reporting Period:
2017-08-21
Accepted Time:
2017-08-23 20:03:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc HQY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179972 G Darcy Mott C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
Executive Vp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-21 12,500 $1.25 84,500 No 4 M Direct
Common Stock Disposition 2017-08-21 9,500 $42.00 75,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-08-21 12,500 $0.00 12,500 $1.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
112,500 2021-08-08 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $41.28 2027-03-27 19,897 19,897 Direct
Common Stock Stock Option (right to buy) $14.00 2024-07-30 30,000 30,000 Direct
Common Stock Stock Option (right to buy) $25.39 2025-03-26 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-03-27 19,897 19,897 Direct
2024-07-30 30,000 30,000 Direct
2025-03-26 25,000 25,000 Direct
Footnotes
  1. The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.78 to $42.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The option is immediately exercisable.
  4. The option becomes exercisable in three annual installments of 4,974 shares on March 27, 2018, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021.
  5. The option became exercisable as to 6,250 shares on each of March 26, 2016 and 2017. The remaining shares become exercisable in two equal annual installments of 6,250 shares on March 26, 2018 and 2019.